Shanghai Public Health Clinical Center
Clinical trials sponsored by Shanghai Public Health Clinical Center, explained in plain language.
-
Could a fourth drug beat a tough infection in HIV patients?
Disease control Not yet recruitingThis study looks at whether adding a fluoroquinolone antibiotic to the usual three-drug treatment helps people with HIV who have a serious infection called disseminated MAC. About 124 adults will be randomly assigned to get either the standard triple therapy or a four-drug regime…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated May 16, 2026 23:34 UTC
-
Steroid shield: new hope to prevent deadly immune Flare-Up in AIDS patients
Prevention Not yet recruitingThis study tests whether a short course of the steroid prednisolone can prevent a serious immune overreaction called IRIS in people with AIDS who have opportunistic infections and are starting HIV therapy. About 262 participants will be randomly assigned to receive either prednis…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated May 16, 2026 23:37 UTC
-
Massive HIV study aims to Fine-Tune therapy for patients with added infections
Knowledge-focused Not yet recruitingThis study will follow 8,000 people with HIV to see how well their antiviral therapy works if they also have an opportunistic infection (like tuberculosis or fungal infections). Researchers will compare viral suppression and immune recovery between those with and without these ex…
Sponsor: Shanghai Public Health Clinical Center • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC